Adam D Bachstetter Selected Research

Adam D Bachstetter Research Topics

Disease

13	Neuroinflammatory Diseases 11/2023 - 11/2011
10	Cognitive Dysfunction 01/2023 - 06/2007
9	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2012
8	Inflammation (Inflammations) 01/2022 - 12/2010
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 04/2015
5	Brain Injuries (Brain Injury) 01/2022 - 01/2016
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2011
4	Closed Head Injuries 10/2023 - 01/2016
4	Dementia (Dementias) 01/2023 - 01/2019
2	Dysbiosis 01/2022 - 01/2022
2	Brain Concussion (Cerebral Concussion) 01/2022 - 01/2022
2	Craniocerebral Trauma (Head Injury) 01/2022 - 04/2015
2	Gliosis 01/2019 - 04/2013
2	Disease Progression 04/2015 - 12/2011
1	Infections 01/2023
1	Neoplasms (Cancer) 01/2023
1	Arteriolosclerosis 01/2023
1	Thoracic Injuries (Chest Injury) 01/2023
1	Atrophy 01/2023
1	Obesity 01/2022
1	Chronic Brain Injury 01/2021
1	Chronic Traumatic Encephalopathy 01/2021
1	TDP-43 Proteinopathies 01/2020
1	Proteostasis Deficiencies 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020
1	Necrosis 01/2019
1	Diffuse Brain Injuries (Diffuse Brain Injury) 01/2017
1	Amyloid Plaque 01/2017
1	Hyperalgesia 01/2016
1	Pain (Aches) 01/2016
1	Disease Susceptibility (Diathesis) 04/2015
1	Hereditary Spastic Paraplegia 12/2013
1	Pelizaeus-Merzbacher Disease 12/2013
1	Parkinson Disease (Parkinson's Disease) 01/2011
1	Neurodevelopmental Disorders 03/2009

Drug/Important Bio-Agent (IBA)

16	CytokinesIBA 01/2023 - 05/2010
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 06/2007
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2017 - 12/2011
3	Protein Isoforms (Isoforms)IBA 04/2015 - 12/2010
2	Interleukin-1 (Interleukin 1)IBA 10/2023 - 01/2021
2	Inulin FDA Link 01/2022 - 01/2022
2	PrebioticsIBA 01/2022 - 01/2022
2	tau Proteins (tau Protein)IBA 01/2021 - 01/2018
2	CX3C Chemokine Receptor 1IBA 11/2011 - 11/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2023
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2023
1	VaccinesIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Volatile Fatty AcidsIBA 01/2022
1	IronIBA 01/2021
1	MAZE protocolIBA 01/2020
1	alpha 2 subunit adaptor protein complex 2IBA 01/2020
1	Mucin-6IBA 01/2020
1	Adaptor Protein Complex 2IBA 01/2020
1	Myosin-Light-Chain KinaseIBA 10/2019
1	DORA-22IBA 01/2019
1	Orexin Receptor AntagonistsIBA 01/2019
1	Purinergic Receptors (Receptors, Purine)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 05/2018
1	methanesulfonate salt 2-hydroxy-4,4'-diamidinostilbeneIBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	MW01-18-150SRMIBA 01/2017
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	LigandsIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	ChemokinesIBA 01/2016
1	CarrageenanIBA 01/2016
1	Arginine (L-Arginine)FDA Link 01/2016
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 01/2016
1	Glial Fibrillary Acidic ProteinIBA 01/2016
1	Protein Kinases (Protein Kinase)IBA 04/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2014
1	Myelin ProteinsIBA 12/2013
1	Amyloid beta-PeptidesIBA 01/2013
1	Presenilin-1IBA 01/2013
1	Chemokine CX3CL1IBA 11/2011
1	Chemokine ReceptorsIBA 11/2011
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2011
1	Polychlorinated Biphenyls (PCBs)IBA 03/2009

Therapy/Procedure

2	Therapeutics 05/2018 - 01/2013
1	Immunotherapy 01/2023
1	Immunomodulation 01/2022
1	Psychosurgery (Lobotomy) 01/2021
1	Intraperitoneal Injections 01/2017